SNY Share Price

Open 49.80 Change Price %
High 49.87 1 Day 0.26 0.53
Low 49.56 1 Week 1.28 2.65
Close 49.59 1 Month 0.59 1.20
Volume 1089619 1 Year 10.46 26.73
52 Week High 50.24
52 Week Low 36.81
SNY Important Levels
Resistance 2 49.88
Resistance 1 49.76
Pivot 49.67
Support 1 49.42
Support 2 49.30
NYSE USA Most Active Stocks
RAD 4.05 30.23%
RAD 4.05 30.23%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
AMD 14.08 -0.64%
AMD 14.08 -0.64%
AMD 14.08 -0.64%
SE 40.68 -0.78%
PCS 11.84 -0.92%
More..
NYSE USA Top Gainers Stocks
RAD 4.05 30.23%
RAD 4.05 30.23%
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
SPA 22.76 24.10%
SPA 22.76 24.10%
SPA 22.76 24.10%
SPA 22.76 24.10%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Sanofi (NYSE: SNY)

SNY Technical Analysis 5
As on 26th Jun 2017 SNY Share Price closed @ 49.59 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 42.37 & Strong Buy for SHORT-TERM with Stoploss of 47.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
SNY Target for June
1st Target up-side 51.3
2nd Target up-side 52.49
3rd Target up-side 53.69
1st Target down-side 47.88
2nd Target down-side 46.69
3rd Target down-side 45.49
SNY Other Details
Segment EQ
Market Capital 99999997952.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.sanofi-aventis.com
SNY Address
SNY
54, Rue La Bo
Paris, 75008
France
Phone: 33 1 53 77 40 00
SNY Latest News
Interactive Technical Analysis Chart Sanofi ( SNY NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sanofi
SNY Business Profile
Sanofi researches, develops, manufactures, and markets healthcare products. The company operates in three segments: Pharmaceuticals, Human Vaccines, and Animal Health. Its products include Lantus and Apidra analogs of human insulin; Insuman human insulin solutions and suspensions; Amaryl, a sulfonylurea; BGStar, iBGStar, and MyStar Extra blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aldurazyme, for mucopolysaccharidosis Type I; Aubagio, a immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for cancers; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company’s products also comprise thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines, including Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela for patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has strategic alliances with Bristol-Myers Squibb, Regeneron, Warner Chilcott, and Regulus Therapeutics Inc., as well as a strategic collaboration with UCB S.A. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.